Today we welcome a guest blog from Chris Gantz, MBA, program manager, Clinical Research Support Office, Recruit Enhancement Core, The Children’s Hospital of Philadelphia Research Institute, who shares why social media and mobile technology are creating opportunities to engage with potential study participants in ways that were not possible just a few years ago.
Read this post about building a Minimal Viable Product (MVP), sixth in a series from CIRP@CHOP Digital Health Initiative experts on creating effective mobile interventions.
Read this post about designing an effective mHealth app, fifth in a series from CIRP@CHOP Digital Health Initiative experts.
Learn about how to listen to your target market to create a viable mHealth app/intervention from the Digital Health Initiative at CHOP.
Read this third installment in a 6-part series on effective mHealth app development. Today's post is about how to use theory and evidence to guide app development.
Learn why when planning an mHealth intervention, it's important to understand the problem and your audience. This informative post is the second in a six-part series on mHealth app development.
Learn about the best practice approaches and steps for developing mHealth apps that have the best chance of improving health from Linda Fleisher, PhD, who leads the Digital Health Initiative at CHOP.
Two overarching themes are beginning to emerge in digital health that are important to public health and align well with CIRP@CHOP’s own digital health research: engagement and effectiveness. Although not new to the digital health research field, they are becoming a priority.
The digital health world is buzzing with recent news about a proposed bill to reduce U.S. Food and Drug Administration (FDA) regulation on “low risk” mobile medical technologies, such as health apps for smartphones that provide health education, management and prevention tools for practitioners and patients. The bill, Preventing Regulatory Overreach to Enhance Care Technology (PROTECT) Act of 2014, aims to amend FDA regulatory guidance on mobile health technologies that are of “low risk” to patient safety. Here's what you should know about the bill.
Read a guest blog post from Darshan Donthi, a sophomore at Drexel University, who shares his insights about about his time as a Drexel co-op student at CIRP@CHOP.